| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Laboratory of Molecular Growth Regulation (S.M., J.C.G.B., K.O) Laboratory of Molecular Embryology (J.W, Y.-B. S, A.P.W) National Institutes of Child Health and Human Development Bethesda, Maryland 20892
Retinoic acid (RA) stimulates transcription from the retinoic acid receptor ß2 (RARß2) promoter in mammalian embryonal cells. Evidence by in vivo deoxyribonuclease I (DNase I) hypersensitivity assay indicates that RA treatment of these cells results in an alteration of chromatin structure in and near the promoter. To study the role of chromatin in RA-activated transcription, we assembled the RARß2 promoter into chromatin in Xenopus oocytes. Ectopic expression of RAR and retinoid X receptor (RXR) enhanced transcription without ligand, irrespective of whether chromatin was assembled in a replication-dependent or -independent manner, although ligand addition led to a further, marked increase in transcription. Moreover, expression of RAR and RXR, without ligand addition, induced DNase I-hypersensitive sites in the chromatin-assembled promoter. Futhermore, expression of RAR and RXR in oocytes led to local disruption of chromatin assembled over the promoter without ligand. Similar ligand-independent, but RXR/RAR-dependent nucleosomal disruption was observed in an in vitro chromatin reconstitution system using Drosophila embryonic extracts. Thus, unliganded receptors expressed in oocytes are capable of accessing to the chromatin-assembled promoter and activating transcription without ligand, indicating that chromatin assembly per se is not sufficient to reproduce ligand-dependent chromatin changes and promoter activation seen in mammalian cells. The oocyte system may serve as a model to study mechanisms of RA-dependent alterations of chromatin structure.
This article has been cited by other articles:
![]() |
S. Segalla, L. Rinaldi, C. Kilstrup-Nielsen, G. Badaracco, S. Minucci, P. G. Pelicci, and N. Landsberger Retinoic Acid Receptor {alpha} Fusion to PML Affects Its Transcriptional and Chromatin-Remodeling Properties Mol. Cell. Biol., December 1, 2003; 23(23): 8795 - 8808. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tomita, D. R. Buchholz, K. Obata, and Y.-B. Shi Fusion Protein of Retinoic Acid Receptor {alpha} with Promyelocytic Leukemia Protein or Promyelocytic Leukemia Zinc Finger Protein Recruits N-CoR-TBLR1 Corepressor Complex to Repress Transcription in Vivo J. Biol. Chem., August 15, 2003; 278(33): 30788 - 30795. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Curradi, A. Izzo, G. Badaracco, and N. Landsberger Molecular Mechanisms of Gene Silencing Mediated by DNA Methylation Mol. Cell. Biol., May 1, 2002; 22(9): 3157 - 3173. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. D. Urnov and A. P. Wolffe A Necessary Good: Nuclear Hormone Receptors and Their Chromatin Templates Mol. Endocrinol., January 1, 2001; 15(1): 1 - 16. [Full Text] |
||||
![]() |
R. Gopal-Srivastava, A. Cvekl, and J. Piatigorsky Involvement of Retinoic Acid/Retinoid Receptors in the Regulation of Murine alpha B-crystallin/Small Heat Shock Protein Gene Expression in the Lens J. Biol. Chem., July 10, 1998; 273(28): 17954 - 17961. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |